Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
134 participants
INTERVENTIONAL
2011-10-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Minocycline in Stroke Study at Maimonides
NCT07237048
Efficacy and Safety of Minocycline in the Treatment of Intracerebral Hemorrhage
NCT07305896
Maimonides Minocycline in Stroke Study
NCT06107725
Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke
NCT05367362
Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke
NCT00630396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Minocicline
minocicline 100mg oral twice a day for 5 days
Minocicline
Minocicline 100mg oral twice a day for 5 days
Placebo
Pills filled with vegetal fiber with similar presentation of the drug. Given one pill oral twice a day for five days
Placebo
Pills with vegetable fibers one pill oral twice a day for five days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Minocicline
Minocicline 100mg oral twice a day for 5 days
Placebo
Pills with vegetable fibers one pill oral twice a day for five days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Onset of symptoms less than 24 hours
* normal Cranial Tomography(CT)
* CT evidence of cerebral ischemia
* Acceptance of study entry
Exclusion Criteria
* Other neurological diseases
* Concomitant structural damage
* History of neurosurgery
* Known allergy to tetracyclines
* Concomitant infectious diseases requiring antibiotic treatment.
* History of Stroke
* Women pregnant or breast-feeding
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Hernando Moncaleano Perdomo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nataly Bedoya
Internist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nataly Bedoya, Internist
Role: STUDY_DIRECTOR
Universidad Surcolombiana
Hernan Vargas, Internist
Role: PRINCIPAL_INVESTIGATOR
Universidad Surcolombiana
Hugo Osorio, Internist
Role: PRINCIPAL_INVESTIGATOR
Universidad Surcolombiana
Guillermo Gonzalez, Neurologist
Role: PRINCIPAL_INVESTIGATOR
Universidad Surcolombiana
Javier Saldaña, Epidemiology
Role: PRINCIPAL_INVESTIGATOR
Universidad Surcolombiana
Efrain Amaya, Neurologist
Role: PRINCIPAL_INVESTIGATOR
Hospital Hernando Moncaleano Perdomo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital hernando Moncaleano Perdomo
Neiva, Huila Department, Colombia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
38212050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.